首页 / 院系成果 / 成果详情页

Potential of Omega-3 Polyunsaturated Fatty Acids in Managing Chemotherapy- or Radiotherapy-Related Intestinal Microbial Dysbiosis  期刊论文  

  • 编号:
    2588f501-abe7-4a5d-b045-a696b25ead7c
  • 作者:
  • 语种:
    英文
  • 期刊:
    ADVANCES IN NUTRITION ISSN:2161-8313 2019 年 10 卷 1 期 (133 - 147) ; JAN
  • 收录:
  • 关键词:
  • 摘要:

    Chemotherapy-or radiotherapy-related intestinalmicrobial dysbiosis is one of the main causes of intestinal mucositis. Cases of bacterial translocation into peripheral blood and subsequent sepsis occur as a result of dysfunction in the intestinal barrier. Evidence from recent studies depicts the characteristics of chemotherapy-or radiotherapy-related intestinal microbial dysbiosis, which creates an imbalance between beneficial and harmful bacteria in the gut. Decreases in beneficial bacteria can lead to a weakening of the resistance of the gut to harmful bacteria, resulting in robust activation of proinflammatory signaling pathways. For example, lipopolysaccharide (LPS)-producing bacteria activate the nuclear transcription factor-kappa B signaling pathway through binding with Toll-like receptor 4 on stressed epithelial cells, subsequently leading to secretion of proinflammatory cytokines. Nevertheless, various studies have found that the omega-3 (n-3) polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid and eicosapentaenoic acid can reverse intestinal microbial dysbiosis by increasing beneficial bacteria species, including Lactobacillus, Bifidobacterium, and butyrate-producing bacteria, such as Roseburia and Coprococcus. In addition, the n-3 PUFAs decrease the proportions of LPS-producing and mucolytic bacteria in the gut, and they can reduce inflammation as well as oxidative stress. Importantly, the n-3 PUFAs also exert anticancer effects in colorectal cancers. In this review, we summarize the characteristics of chemotherapy-or radiotherapy-related intestinalmicrobial dysbiosis and introduce the contributions of dysbiosis to the pathogenesis of intestinal mucositis. Next, we discuss how n-3 PUFAs could alleviate chemotherapy-or radiotherapy-related intestinal microbial dysbiosis. This review provides new insights into the clinical administration of n-3 PUFAs for the management of chemotherapy-or radiotherapy-related intestinal microbial dysbiosis.

  • 推荐引用方式
    GB/T 7714:
    Zhang Yue,Zhang Boyan,Dong Lihua, et al. Potential of Omega-3 Polyunsaturated Fatty Acids in Managing Chemotherapy- or Radiotherapy-Related Intestinal Microbial Dysbiosis [J].ADVANCES IN NUTRITION,2019,10(1):133-147.
  • APA:
    Zhang Yue,Zhang Boyan,Dong Lihua,Chang Pengyu.(2019).Potential of Omega-3 Polyunsaturated Fatty Acids in Managing Chemotherapy- or Radiotherapy-Related Intestinal Microbial Dysbiosis .ADVANCES IN NUTRITION,10(1):133-147.
  • MLA:
    Zhang Yue, et al. "Potential of Omega-3 Polyunsaturated Fatty Acids in Managing Chemotherapy- or Radiotherapy-Related Intestinal Microbial Dysbiosis" .ADVANCES IN NUTRITION 10,1(2019):133-147.
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:83 下载次数:0
浏览次数:83
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部